$BDPT News

BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery

BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle

BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night

BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing

BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience

BioAdaptives Announces National Launch of Pawpa™ Regen

BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements

Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial

BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors

BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors

BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders

BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health

BioAdaptives, Inc.’s Board of Directors Approves a One-for-One Stock Dividend

BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™

BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace

BioAdaptives, Inc. Announces Complete Product Overhaul with New Line of Scientifically Advanced Solutions

BioAdaptives, Inc. Letter to Shareholders Regarding the Reverse Stock Split

BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors

BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives